The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Outcome of patients (pts) with renal medullary carcinoma (RMC) treated in the era of targeted therapies (TT): A multicenter experience.
Nizar M. Tannir
No relevant relationships to disclose
Zita Dubauskas Lim
No relevant relationships to disclose
B. Nebiyou Bekele
No relevant relationships to disclose
Ewan Douglas Johnson
No relevant relationships to disclose
Pheroze Tamboli
No relevant relationships to disclose
Ulka N. Vaishampayan
No relevant relationships to disclose
Elizabeth Rosenberg Plimack
No relevant relationships to disclose
Kimryn Rathmell
No relevant relationships to disclose
Eric Jonasch
No relevant relationships to disclose